29 November 2019
Oncode Institute invests 4 million euros in new technology for cancer research in the Netherlands
Oncode Institute invests 4 million euros in unique, state-of-the-art technology for cancer research. Five projects have been awarded within the Infrastructure & Technologies Programme. These technologies will not only become available for the twelve institutes that are affiliated with Oncode Institute but will also be made available to the wider research community in the Netherlands.
10 December 2019
Oncode Investigators Elzo de Wit and Ruben van Boxtel receive ERC Grant
Oncode Institute is proud to announce that Oncode Investigators Elzo de Wit (Netherlands Cancer Institute) and Ruben van Boxtel (Princess Máxima Center) both receive the ERC Consolidator Grant. The ERC Consolidator Grants are awarded to outstanding researchers with at least seven and up to twelve years of experience after PhD, and a scientific track record showing great promise.
29 November 2019
Researchers explain the added value of Oncode Institute
At this year's Oncode-CGC Annual conference, we took the time to speak with some of our Oncode Investigators. In this video, they explain the value that Oncode adds to their research, collaboration opportinuties and valorization success.
28 November 2019
Biotech Wednesday: Joining forces to outsmart cancer – new frontiers in cell therapy
United by a desire to bring new cell therapies to patients, Oncode Institute and HollandBIO brought together academia, life sciences companies, clinicians and other relevant stakeholders at this first of its kind event.
7 November 2019
Oncode is hiring!
Interested in joining us? Oncode is an independent institute dedicated to understanding cancer and translating research into practice more efficiently. Oncode, starting from a deeper understanding of the basics of cancer, works to come up with better treatments and improved diagnostics.
Fundamental science, clinical testing and a sharp mind for market opportunities: at Oncode we bring it all together to create impact for patients.